Literature DB >> 9162609

The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults.

T J Thompson1, M M Engelgau, M Hegazy, M A Ali, E S Sous, A Badran, W H Herman.   

Abstract

The onset of diabetes relative to clinical diagnosis was estimated in Egyptians with non-insulin-dependent diabetes mellitus (NIDDM) based on the relationship between retinopathy and duration of diabetes. Between July 1992 and October 1993 the Diabetes in Egypt (DIE) Project performed a cross-sectional, population-based survey with clinical and laboratory follow-up to describe the prevalence of microvascular, neuropathic, and macrovascular complications among Egyptians > or = 20 years of age with diagnosed diabetes, previously undiagnosed diabetes, impaired glucose tolerance, and normal glucose tolerance. The sample of persons with diabetes diagnosed prior to the survey had medical examinations which included a dilated eye examination and retinal photographs. Generalized linear models were used to relate the probability of retinopathy to duration of diabetes. Among 218 persons with diabetes diagnosed prior to the DIE project, 87 (40%) had diabetic retinopathy. The onset of retinopathy was estimated to occur 2.6 years (p = 0.04) prior to clinical diagnosis. The estimated annual incidence of retinopathy was 5% and the estimated prevalence at the time of clinical diagnosis of diabetes was 12%. On the basis of reports that retinopathy does not occur until approximately 5 years after the development of diabetes, the onset of NIDDM was estimated to occur 7.6 years prior to its clinical diagnosis. This estimate of the onset of NIDDM in Egyptians is comparable to other estimates reported for US and Australian populations.

Entities:  

Mesh:

Year:  1996        PMID: 9162609     DOI: 10.1002/(SICI)1096-9136(199604)13:4<337::AID-DIA71>3.0.CO;2-A

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

1.  Clinical implication of fasting and post-challenged plasma glucose in diagnosis of diabetes mellitus.

Authors:  Jean Huang; Horng-Yih Ou; Rudruidee Karnchanasorn; Raynald Samoa; Lee-Ming Chuang; Ken C Chiu; Wei Feng
Journal:  Endocrine       Date:  2014-06-04       Impact factor: 3.633

2.  The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

Authors:  William H Herman; Thomas J Hoerger; Michael Brandle; Katherine Hicks; Stephen Sorensen; Ping Zhang; Richard F Hamman; Ronald T Ackermann; Michael M Engelgau; Robert E Ratner
Journal:  Ann Intern Med       Date:  2005-03-01       Impact factor: 25.391

Review 3.  Diabetes and pancreatic cancer.

Authors:  T Muniraj; S T Chari
Journal:  Minerva Gastroenterol Dietol       Date:  2012-12

4.  Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2.

Authors:  David C Ziemer; Paul Kolm; Jovonne K Foster; William S Weintraub; Viola Vaccarino; Mary K Rhee; Rincy M Varughese; Circe W Tsui; David D Koch; Jennifer G Twombly; K M Venkat Narayan; Lawrence S Phillips
Journal:  J Gen Intern Med       Date:  2008-03-12       Impact factor: 5.128

5.  Establishment of Health Clinics as Mass Screening and Referral Systems for Chronic Non-communicable Diseases in Primary Health Care.

Authors:  Kamal Heidari; Sayyed Ali Sajjadi; Rezvaneh Hadian; Somayeh Hadi; Ramesh Hosseinkhani; Soudabeh Amini; Zahra Kiani; Ali Ajami; Reza Fadaei; Anahita Shahriari; Kasra Keramatian
Journal:  Int J Prev Med       Date:  2012-03

6.  Is it time to take a different approach to screening people at high risk for type 1 diabetes?

Authors:  Edward J Boyko; Jerry P Palmer
Journal:  Diabetes Care       Date:  2009-05       Impact factor: 19.112

Review 7.  Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.

Authors:  P I Burgess; I J C MacCormick; S P Harding; A Bastawrous; N A V Beare; P Garner
Journal:  Diabet Med       Date:  2013-04       Impact factor: 4.359

8.  Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe).

Authors:  William H Herman; Wen Ye; Simon J Griffin; Rebecca K Simmons; Melanie J Davies; Kamlesh Khunti; Guy E H M Rutten; Annelli Sandbaek; Torsten Lauritzen; Knut Borch-Johnsen; Morton B Brown; Nicholas J Wareham
Journal:  Diabetes Care       Date:  2015-05-18       Impact factor: 19.112

9.  Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients Attending the Diabetic Clinic of the University of Gondar Hospital, Northwest Ethiopia.

Authors:  Asamere Tsegaw; Shitaye Alemu; Abere Dessie; Christopher C Patterson; Eldryd H O Parry; David I W Phillips; Elisabeth R Trimble
Journal:  J Ophthalmol       Date:  2021-03-31       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.